Pages that link to "Q35180073"
Jump to navigation
Jump to search
The following pages link to Postprandial insulin secretion after gastric bypass surgery: the role of glucagon-like peptide 1 (Q35180073):
Displaying 15 items.
- Type 2 diabetes: etiology and reversibility (Q27016644) (← links)
- Transforming a Biliopancreatic Derivation in an Ileal Interposition with a Single Anastomosis (Q33465327) (← links)
- Removal of duodenum elicits GLP-1 secretion (Q36868293) (← links)
- Early Outcomes of Roux-en-Y Gastric Bypass in a Publically Funded Obesity Program (Q37515340) (← links)
- Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass (Q38005896) (← links)
- Therapies for inter-relating diabetes and obesity - GLP-1 and obesity (Q38254745) (← links)
- Weight Management in Patients with Type 1 Diabetes and Obesity. (Q41504692) (← links)
- Potential Hormone Mechanisms of Bariatric Surgery. (Q41625381) (← links)
- Synthesis and evaluation of novel lipidated neuromedin U analogs with increased stability and effects on food intake (Q41674388) (← links)
- Stomachs: does the size matter? Aspects of intestinal satiety, gastric satiety, hunger and gluttony (Q42560394) (← links)
- Changes in gastrointestinal hormone responses, insulin sensitivity, and beta-cell function within 2 weeks after gastric bypass in non-diabetic subjects (Q44621765) (← links)
- Assessment of glucose regulation in pregnancy after gastric bypass surgery. (Q47973244) (← links)
- Calorie restriction and not glucagon-like peptide-1 explains the acute improvement in glucose control after gastric bypass in Type 2 diabetes (Q50259673) (← links)
- Mechanisms in bariatric surgery: Gut hormones, diabetes resolution, and weight loss. (Q55081525) (← links)
- GLP-1 Receptor Agonist Treatment in Morbid Obesity and Type 2 Diabetes Due to Pathogenic Homozygous Melanocortin-4 Receptor Mutation: A Case Report (Q102144605) (← links)